Hematology Drugs See Largest Market In Asia Pacific At Over 35% Of The Global Market Share As Per The Business Research Company’s Hematology Drugs Global Market Report 2021

LONDON, Sept. 28, 2021 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the hematology drugs market, Asia Pacific was the largest region in the hematology drugs market, accounting for 35.6% of the total in 2020. It was followed by the North America, Western Europe and then the other regions. The growth of the hematology drugs market in the Asia-Pacific is supported by increasing prevalence of chronic blood disorders. According to the Global Hemophilia Care 2019 report, more than 1,125,000 men around the world have an inherited bleeding disorder, and 418,000 of those have a severe version of the mostly undiagnosed disease. In addition, about 400,000 people globally were estimated to have hemophilia.

Early diagnosis and treatment are the best ways to protect the life of a patient with blood cell disorder. The hematology drugs industry develops drugs to cure, treat, or prevent disease that mainly affect the blood and blood-forming organs. Hematology drugs are subject to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing.

Growth in the pharmaceuticals drugs market in Asia Pacific has a positive impact on the hematology drugs market. Lupin, Clinimed Lifesciences, Innovent Biologics, Incyte, F. Hoffmann-La Roche AG, Telix Pharmaceuticals Ltd., Scintec Diagnostics GmbH, GC Pharma Takeda Pharmaceutical Company, Daiichi Sankyo Company are the major companies in the hematology drugs market in the Asia-Pacific region.

Going forward, the fastest-growing regions in the hematology drugs market will be South America and Africa where growth will be at CAGRs of 12.0% and 11.5% respectively during 2020-2025. These will be followed by Middle East and Eastern Europe, where the markets are expected to register CAGRs of 11.2% and 8.5% respectively during 2020-2025.

The Business Research Company’s report titled Hematology Drugs Global Market Report 2021 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery covers major hematology drugs companies, hematology drugs market share by company, hematology drugs manufacturers, hematology drugs market size, and hematology drugs market forecasts. The report also covers the global hematology drugs market and its segments.

Request For A Sample Of The Global Hematology Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2137&type=smp

The global hematology drugs market size is expected to grow from $78.83 billion in 2020 at a rate of 4.7%, leading to the hematology drugs market 2021 being worth $82.57 billion. The growth in the drugs for hematology market size, share, 2021 is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $119.92 billion in 2025 at a CAGR of 10%.

The hematology drugs market is segmented by type into hemophilia, anemia, blood products and other blood disorder drugs. The hemophilia was the largest segment of the hematology drugs market segmented by type, accounting for 52.2% of the total in 2020. Going forward, the blood products segment is expected to be the fastest growing segment in the hematology drugs market segmented by type, at a CAGR of 10.8% during 2020-2025. The hematology market is also segmented by distribution channel into hospital pharmacies, retail pharmacies/ drug stores, others, by route of administration into oral, parenteral, others, by drug classification into branded drugs, generic drugs, and by mode of purchase into prescription-based drugs, over-the-counter drugs.

Hematology Drugs Global Market Report 2021 – COVID-19 Impact And Recovery is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, segments and geographies, trends, drivers, restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports By The Business Research Company:

Anemia And Other Blood Disorder Drugs Global Market Report 2021 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy), By Route of Administration (Oral, Injectable), By Anemia Type (Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)), COVID-19 Impact And Recovery

Antithrombotic Drugs Market – By Type Of Product (Anticoagulant Drugs, Antiplatelet Drugs, Thrombolytic Drugs), By Application (Blood Clot And Thromboembolic Treatment, Hyperlipidemia Treatment, Prophylactic Treatment, Other Applications), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Retailers, Drug Stores), And By Region, Opportunities And Strategies – Global Forecast To 2030

Blood Transfusion Diagnostics Global Market Report 2021 – By Type (Instruments and Kits, Reagents), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test), By Application (Blood Grouping, Disease Screening), COVID-19 Growth And Change

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.